Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Bad
|
New words:
accrual, actuarially, admissibility, agentHyzaar, alendronate, analog, andAvelox, andJanumet, andMiraLAX, andSinemet, andVaseretic, andVytorin, antipsychotic, AOCI, applied, approvedCosopt, approvedJanumet, approvedZioptan, aprepitant, asEzetrol, asFosavance, aspirin, asResearch, asSaflutan, asTemodal, Atherothrombotic, attack, bearing, beneficiary, biennial, blinded, Cardiology, Carter, chapter, check, cleanup, College, Colorado, commonly, coronary, correct, Cosmetic, David, death, defrauded, diabetic, digit, disposal, disposed, dorzolamide, drafting, DSMB, edition, electronically, Employer, Endocyte, enforceable, England, enjoining, enlargement, enumerated, equivalent, etonogestrel, evidentiary, experience, filer, forCosopt, forCozaarandHyzaarin, forDulera, forFosamax, forMaxalt, forSycrest, forZostavaxin, frame, fromAOCI, fulfill, fulfilling, gave, Gleeson, greatly, guilty, handling, history, Identification, inAOCIuntil, incentive, includeCozaar, inCozaar, inErnst, infliximab, insolvency, Interactive, intracranial, involvingPropecia, Ischemic, isde, ITC, Jessica, Joel, Journal, launchCosopt, leave, leverage, leveraged, loratadine, losartan, lung, manufactureNuvaRing, marketCozaar, marketRemicade, Mayer, MerckandJellema, Merckwere, Middlesex, minimisand, mirtazapine, misbranding, misdemeanor, mometasone, moot, moxifloxacin, OCI, ofBridion, ofcertiorari, ofCosopt, ofIntegrilin, ofRemicade, ofSimponi, ofVaqta, Ohio, online, onPrimaxin, orVytorin, pain, pancreatic, Perk, PF, Pisano, plea, plead, posaconazole, post, posted, preceding, precluded, prescriptionClaritin, pretrial, promote, promoting, promotion, Proscar, protocol, published, raltegravir, recalcitrant, rescheduled, rest, resumed, retrospectively, revascularization, rizatriptan, rodent, satisfactory, secondary, selectedScheinberg, Session, severalVioxx, shell, shorter, smaller, Station, Steven, summer, Superfund, syndrome, temozolomide, testimony, thatNuvaRing, theCain, theFosamax, theNuvaRing, theSessner, theTemodar, thienopyridine, Thrombin, timetable, TIMI, toJanuvia, Torrent, toSimponi, toSinemet, toSycrest, TRACER, unadjusted, underwriter, urgent, vintafolide, Virginia, vorapaxar, Web, Whitehouse, withSessner
Removed:
abandoned, acquirer, acquisition, addiction, adjuvant, affiliated, affirmed, albuterol, allocating, andCerazette, anhydrase, announcement, anticipation, approximate, arrangement, asEzetroloutside, asFosavancethroughout, asserted, assetsare, assumption, asTemodaloutside, atrial, awarded, bancof, Bauer, Benckiser, black, blocking, branded, breast, bronchospasm, BsF, carbonic, Cardiome, certainty, challenge, cherry, CID, commercializing, composition, contrary, convenience, conversion, convert, cooperating, counting, cover, dealer, decade, deliverable, demand, denying, deteriorate, deteriorating, devaluation, devalued, disputed, distribute, Dohme, economy, effectively, Endocrine, enterprise, evidence, exhausted, expand, fibrillation, finalization, finalized, flavor, floating, forCosoptandTrusoptexpired, forCosoptwill, forGardasilfor, forRemicadeandSimponito, forSycrestsublingual, forZostavaxfor, fromRemicadeandSimponi, FTC, gastrointestinal, globally, granting, ground, hyperinflationary, Idaho, identified, Immunology, implemented, improvement, includeCozaarandHyzaar, inclusion, incorporate, IndianaVioxx, Inspire, interestson, internationally, intoSaleswhen, intraepithelial, Investigative, investmentstotaled, involvement, Kaposi, leading, licensor, liquid, lymphadenectomy, maintained, managerial, mandated, marketplace, melanoma, methotrexate, Mexico, Michigan, microscopic, modified, National, neoplasia, nextFosamaxMDL, nodal, Norway, ofCosoptophthalmic, ofCozaarand, official, ofGardasilrecorded, ofGardasilwere, ofOther, ofProQuadfor, ofRecombivax, ofRotaTeq, ofSaphrisin, ofSimponiwere, ofSingulairin, Oklahoma, onPrimaxinhave, onset, Ophthalmology, opiate, opposition, overpay, Pennsylvania, percent, pregnancy, prejudgment, presently, preside, prioritization, productionof, progressive, prospectively, protection, psychotic, quantity, rapid, rebate, recast, Reckitt, recognition, refer, refund, remained, remeasure, replace, resection, residual, responding, retiree, rhythm, Ronald, ruling, SAP, severalVioxxProduct, sharp, skilled, spent, split, statute, statutory, Stockpile, strong, subsidy, surgical, surviving, taste, taxation, taxing, theFosamaxproduct, theVioxxERISA, theVioxxInvestigation, theVioxxLegal, theVioxxLitigation, theVioxxSettlement, theVioxxShareholder, topical, toRemicadeandSimponi, toSaleseach, toSinemetandSinemet, toSycrestin, traded, transitioned, treble, Twelve, unanimously, unavailability, uncertain, unrelated, unresolved, unsupported, updated, Utah, utilization, valuation, vast, vendor, Venezuela, Venezuelan, VioxxERISA, VioxxInvestigation, VioxxLegal, VioxxLitigation, wide, Wisconsin, withPegIntronfor
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 4.1 Third Supplemental Indenture, Dated May 1, 2012
- 10.1 Performance Share Unit Terms for 2012 Grants
- 31.1 Rule 13A - 14(A)/15D -14(A) Certification of Chief Executive Officer
- 31.2 Rule 13A - 14(A)/15D -14(A) Certification of Chief Financial Officer
- 32.1 Section 1350 Certification of Chief Executive Officer
- 32.2 Section 1350 Certification of Chief Financial Officer
Related press release
MRK similar filings
Filing view
External links